188 related articles for article (PubMed ID: 29776342)
21. Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.
Park SY; Seo AN; Jung HY; Gwak JM; Jung N; Cho NY; Kang GH
PLoS One; 2014; 9(6):e100429. PubMed ID: 24971511
[TBL] [Abstract][Full Text] [Related]
22. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
[TBL] [Abstract][Full Text] [Related]
23. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
24. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract][Full Text] [Related]
25. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
26. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
Xu Z; Sandler DP; Taylor JA
J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer.
Salas LA; Lundgren SN; Browne EP; Punska EC; Anderton DL; Karagas MR; Arcaro KF; Christensen BC
Hum Mol Genet; 2020 Mar; 29(4):662-673. PubMed ID: 31943067
[TBL] [Abstract][Full Text] [Related]
28. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
29. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
[TBL] [Abstract][Full Text] [Related]
30. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
[TBL] [Abstract][Full Text] [Related]
31. Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.
Cheishvili D; Parashar S; Mahmood N; Arakelian A; Kremer R; Goltzman D; Szyf M; Rabbani SA
J Bone Miner Res; 2018 Nov; 33(11):1980-1989. PubMed ID: 29924424
[TBL] [Abstract][Full Text] [Related]
32. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
Yeung KS; Chung BH; Choufani S; Mok MY; Wong WL; Mak CC; Yang W; Lee PP; Wong WH; Chen YA; Grafodatskaya D; Wong RW; Lau CS; Chan DT; Weksberg R; Lau YL
PLoS One; 2017; 12(1):e0169553. PubMed ID: 28085900
[TBL] [Abstract][Full Text] [Related]
34. A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression.
Zhang Y; Zhang J; Liu Z; Liu Y; Tuo S
Biochem Biophys Res Commun; 2015 Sep; 465(3):437-42. PubMed ID: 26282201
[TBL] [Abstract][Full Text] [Related]
35. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
36. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation.
Li K; Qin L; Jiang S; Li A; Zhang C; Liu G; Sun J; Sun H; Zhao Y; Li N; Zhang Y
Clin Epigenetics; 2020 Jun; 12(1):81. PubMed ID: 32513305
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.
Smith AK; Conneely KN; Pace TW; Mister D; Felger JC; Kilaru V; Akel MJ; Vertino PM; Miller AH; Torres MA
Brain Behav Immun; 2014 May; 38():227-36. PubMed ID: 24583204
[TBL] [Abstract][Full Text] [Related]
38. Whole genome DNA methylation signature of HER2-positive breast cancer.
Lindqvist BM; Wingren S; Motlagh PB; Nilsson TK
Epigenetics; 2014 Aug; 9(8):1149-62. PubMed ID: 25089541
[TBL] [Abstract][Full Text] [Related]
39. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
40. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]